US Stock MarketDetailed Quotes

Virax Biolabs (VRAX)

Watchlist
  • 0.3090
  • +0.0740+31.49%
Close May 19 16:00 ET
  • 0.2700
  • -0.0390-12.62%
Pre 07:02 ET
2.29MMarket Cap-0.25P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Virax Biolabs (VRAX) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Mar 31, 2025
(FY)Mar 31, 2024
(FY)Mar 31, 2023
(FY)Mar 31, 2022
(FY)Mar 31, 2021
(FY)Mar 31, 2020
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
26.95%-4.56M
-49.46%-6.25M
-416.61%-4.18M
-37.09%-809.07K
20.74%-590.19K
-744.61K
Net income from continuing operations
9.97%-6.07M
-23.48%-6.74M
-211.90%-5.46M
-160.04%-1.75M
9.00%-672.92K
---739.46K
Operating gains losses
1,506.65%123.74K
97.01%-8.8K
-482,513.11%-294.27K
101.58%61
-494.80%-3.87K
--981
Depreciation and amortization
233.07%343.39K
--103.1K
--0
--0
----
----
Other non cash items
-60.52%45.6K
477.52%115.5K
-93.25%20K
997.95%296.35K
-70.24%26.99K
--90.69K
Change In working capital
155.86%625.62K
-514.28%-1.12M
-128.30%-182.33K
980.99%644.39K
161.57%59.61K
---96.82K
-Change in receivables
200.83%219.66K
---217.84K
--0
200.00%928
---928
--0
-Change in inventory
43.21%-34.29K
-388.21%-60.38K
17,214.88%20.95K
100.57%121
---21.07K
--0
-Change in prepaid assets
88.50%-26.6K
16.03%-231.31K
-12,707.60%-275.48K
--2.19K
--0
----
-Change in payables and accrued expense
181.58%466.85K
-1,785.95%-572.25K
-94.71%33.94K
685.62%641.16K
184.29%81.61K
---96.82K
-Change in other working capital
----
-200.00%-38.25K
--38.25K
----
----
----
Cash from discontinued investing activities
Operating cash flow
26.95%-4.56M
-49.46%-6.25M
-416.61%-4.18M
-37.09%-809.07K
20.74%-590.19K
---744.61K
Investing cash flow
Cash flow from continuing investing activities
48.14%-603.89K
-552.71%-1.16M
-178.4K
0
Net PPE purchase and sale
36.60%-603.89K
---952.5K
--0
--0
----
----
Net intangibles purchase and sale
--0
-18.81%-211.95K
---178.4K
--0
----
----
Cash from discontinued investing activities
Investing cash flow
48.14%-603.89K
-552.71%-1.16M
---178.4K
--0
----
----
Financing cash flow
Cash flow from continuing financing activities
252.34%5.81M
-87.96%1.65M
1,583.33%13.69M
38.96%813.21K
-16.95%585.2K
704.64K
Net issuance payments of debt
47.76%-107.76K
-241.04%-206.27K
46.25%146.25K
--100K
--0
----
Net common stock issuance
2,191,432.48%5.13M
-100.00%234
2,527.79%13.65M
--519.61K
----
----
Proceeds from stock option exercised by employees
-57.98%786.74K
--1.87M
--0
--0
----
----
Net other financing activities
----
83.61%-18.3K
-157.67%-111.65K
-66.92%193.59K
-16.95%585.2K
--704.64K
Cash from discontinued financing activities
Financing cash flow
252.34%5.81M
-87.96%1.65M
1,583.33%13.69M
38.96%813.21K
-16.95%585.2K
--704.64K
Net cash flow
Beginning cash position
-61.62%3.59M
42,888.32%9.35M
23.47%21.76K
-22.06%17.62K
-63.87%22.61K
--62.58K
Current changes in cash
111.10%639.7K
-161.77%-5.76M
225,553.74%9.33M
182.90%4.14K
87.52%-4.99K
---39.97K
End cash Position
17.82%4.23M
-61.62%3.59M
42,888.32%9.35M
23.47%21.76K
-22.06%17.62K
--22.61K
Free cash flow
30.28%-5.17M
-70.06%-7.41M
-438.66%-4.36M
-37.09%-809.07K
20.74%-590.19K
---744.61K
Currency Unit
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion with Explanatory Notes
Unqualified Opinion
Unqualified Opinion with Explanatory Notes
Unqualified Opinion with Explanatory Notes
--
--
(FY)Mar 31, 2025(FY)Mar 31, 2024(FY)Mar 31, 2023(FY)Mar 31, 2022(FY)Mar 31, 2021(FY)Mar 31, 2020
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 26.95%-4.56M-49.46%-6.25M-416.61%-4.18M-37.09%-809.07K20.74%-590.19K-744.61K
Net income from continuing operations 9.97%-6.07M-23.48%-6.74M-211.90%-5.46M-160.04%-1.75M9.00%-672.92K---739.46K
Operating gains losses 1,506.65%123.74K97.01%-8.8K-482,513.11%-294.27K101.58%61-494.80%-3.87K--981
Depreciation and amortization 233.07%343.39K--103.1K--0--0--------
Other non cash items -60.52%45.6K477.52%115.5K-93.25%20K997.95%296.35K-70.24%26.99K--90.69K
Change In working capital 155.86%625.62K-514.28%-1.12M-128.30%-182.33K980.99%644.39K161.57%59.61K---96.82K
-Change in receivables 200.83%219.66K---217.84K--0200.00%928---928--0
-Change in inventory 43.21%-34.29K-388.21%-60.38K17,214.88%20.95K100.57%121---21.07K--0
-Change in prepaid assets 88.50%-26.6K16.03%-231.31K-12,707.60%-275.48K--2.19K--0----
-Change in payables and accrued expense 181.58%466.85K-1,785.95%-572.25K-94.71%33.94K685.62%641.16K184.29%81.61K---96.82K
-Change in other working capital -----200.00%-38.25K--38.25K------------
Cash from discontinued investing activities
Operating cash flow 26.95%-4.56M-49.46%-6.25M-416.61%-4.18M-37.09%-809.07K20.74%-590.19K---744.61K
Investing cash flow
Cash flow from continuing investing activities 48.14%-603.89K-552.71%-1.16M-178.4K0
Net PPE purchase and sale 36.60%-603.89K---952.5K--0--0--------
Net intangibles purchase and sale --0-18.81%-211.95K---178.4K--0--------
Cash from discontinued investing activities
Investing cash flow 48.14%-603.89K-552.71%-1.16M---178.4K--0--------
Financing cash flow
Cash flow from continuing financing activities 252.34%5.81M-87.96%1.65M1,583.33%13.69M38.96%813.21K-16.95%585.2K704.64K
Net issuance payments of debt 47.76%-107.76K-241.04%-206.27K46.25%146.25K--100K--0----
Net common stock issuance 2,191,432.48%5.13M-100.00%2342,527.79%13.65M--519.61K--------
Proceeds from stock option exercised by employees -57.98%786.74K--1.87M--0--0--------
Net other financing activities ----83.61%-18.3K-157.67%-111.65K-66.92%193.59K-16.95%585.2K--704.64K
Cash from discontinued financing activities
Financing cash flow 252.34%5.81M-87.96%1.65M1,583.33%13.69M38.96%813.21K-16.95%585.2K--704.64K
Net cash flow
Beginning cash position -61.62%3.59M42,888.32%9.35M23.47%21.76K-22.06%17.62K-63.87%22.61K--62.58K
Current changes in cash 111.10%639.7K-161.77%-5.76M225,553.74%9.33M182.90%4.14K87.52%-4.99K---39.97K
End cash Position 17.82%4.23M-61.62%3.59M42,888.32%9.35M23.47%21.76K-22.06%17.62K--22.61K
Free cash flow 30.28%-5.17M-70.06%-7.41M-438.66%-4.36M-37.09%-809.07K20.74%-590.19K---744.61K
Currency Unit USDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion with Explanatory NotesUnqualified OpinionUnqualified Opinion with Explanatory NotesUnqualified Opinion with Explanatory Notes----
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +25.02%
Sample Name
Sample Code
 +19.33%
Sample Name
Sample Code
 +19.27%
4
United States Gasoline Fund Lp
UGA
+17.87%
5
United Sts Brent Oil Fd Lp Unit
BNO
+17.46%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +9.46%
Sample Name
Sample Code
 +2.83%
Sample Name
Sample Code
 +2.79%
4
PDD Holdings
PDD
+1.68%
5
KE Holdings
BEKE
+1.08%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 19, Eastern Time, Trump issued a clear countdown: 'in two or three days—maybe Friday, Saturday, Sunday, or early next week'—the U.S. Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -